These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15893199)

  • 1. The optimal low-density lipoprotein is 50 to 70 mg/dl.
    Clendenning R
    J Am Coll Cardiol; 2005 May; 45(10):1732; author reply 1732. PubMed ID: 15893199
    [No Abstract]   [Full Text] [Related]  

  • 2. [LDL cholesterol--why lower and lower?].
    Müller-Wieland D; Kotzka J
    MMW Fortschr Med; 2007 May; 149(22):28-30. PubMed ID: 18069223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Which study conclusions favor so-called primary prevention of increased cholesterol values, which speak against prevention and what therapy guidelines are reliable?].
    Steinmetz A
    Internist (Berl); 1994 Sep; 35(9):880-1. PubMed ID: 7960571
    [No Abstract]   [Full Text] [Related]  

  • 4. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
    Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
    Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction.
    Farwell WR; Sesso HD; Buring JE; Gaziano JM
    Am J Cardiol; 2005 Oct; 96(8):1129-34. PubMed ID: 16214451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol.
    DeFaria Yeh D; Freeman MW; Meigs JB; Grant RW
    Am J Cardiol; 2007 Jan; 99(1):1-4. PubMed ID: 17196452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for targeted rather than population based screening with C-reactive protein using the National Health and Nutrition Examination Survey (1999 to 2002).
    Guttormsen BN; Stein JH; McBride PE; Cullen MW; Gangnon R; Keevil JG
    Am J Cardiol; 2007 Oct; 100(7):1130-3. PubMed ID: 17884376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications from the Air Force/Texas Coronary Atherosclerosis Prevention Study for the Adult Treatment Panel III guidelines.
    Clearfield M; Downs JR; Lee M; Langendorfer A; McConathy W; Gotto AM
    Am J Cardiol; 2005 Dec; 96(12):1674-80. PubMed ID: 16360356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory cytokine gene variants in coronary artery disease patients in Greece.
    Manginas A; Tsiavou A; Chaidaroglou A; Giamouzis G; Degiannis D; Panagiotakos D; Cokkinos DV
    Coron Artery Dis; 2008 Dec; 19(8):575-82. PubMed ID: 19005292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
    Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
    Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Even if LDL and triglycerides are within normal limits, low HDL increases risk of infarction].
    MMW Fortschr Med; 2004 May; 146(21):59. PubMed ID: 15373089
    [No Abstract]   [Full Text] [Related]  

  • 13. [Severe progression of coronary heart disease in a patient with elevated lipoprotein (a) level in spite of optimal LDL-C decrease].
    Fischer S; Julius U; Bergmann S; Hohensee H; Bornstein SR; Strasser RH
    Herz; 2007 Oct; 32(7):578-82. PubMed ID: 17972032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum cholesterol and long-term prognosis in middle-aged men with myocardial infarction and angina pectoris. A 16-year follow-up of the Primary Prevention Study in Göteborg, Sweden.
    Rosengren A; Hagman M; Wedel H; Wilhelmsen L
    Eur Heart J; 1997 May; 18(5):754-61. PubMed ID: 9152645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
    Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
    Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Are high levels of HDL always associated with a reduced risk of myocardial infarction? - lipid therapy should still focus on lowering LDL cholesterol levels].
    Laufs U
    Dtsch Med Wochenschr; 2012 Oct; 137(43):2200. PubMed ID: 23076665
    [No Abstract]   [Full Text] [Related]  

  • 18. [Summary of a dissertation. Cholesterol screening].
    Pirich C
    Wien Klin Wochenschr; 1990 Oct; 102(19):576-9. PubMed ID: 2281673
    [No Abstract]   [Full Text] [Related]  

  • 19. [The 10-minute consultation: accidently discovered hypercholesteremia].
    Tatò F
    MMW Fortschr Med; 2004 Sep; 146(35-36):59-60. PubMed ID: 15540545
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipoprotein (a) as a risk factor for atherosclerotic diseases.
    Dahlén G
    Arctic Med Res; 1988; 47 Suppl 1():458-61. PubMed ID: 2978804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.